Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Eriodictyol 7-o-beta-rutinoside
1. Eriodictioside
2. 13463-28-0
3. Eriodictyol-7-o-rutinoside
4. Eriodictyol 7-o-rutinoside
5. Chebi:28709
6. Eriodictyol 7-rutinoside
7. As293hr5xq
8. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2h-chromen-7-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
9. Unii-as293hr5xq
10. Eriodictyol 7-o-beta-rutinoside
11. Einecs 236-668-7
12. Eriodictyol Glycoside
13. Eriocitrin [who-dd]
14. Schembl750974
15. Eriocitrin, Analytical Standard
16. Chembl2165586
17. Dtxsid60864408
18. Eriocitrin, >=98.0% (hplc)
19. Ex-a6774
20. Hy-n0636
21. Zinc8234294
22. Bdbm50462417
23. Mfcd28016053
24. S9211
25. Akos030573687
26. Ccg-208387
27. Ncgc00163549-01
28. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
29. (s)-7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-4h-benzopyran-4-one
30. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (s)-
31. As-75208
32. Cs-0009665
33. C09732
34. A910366
35. Sr-05000002278
36. Eriocitrin, Primary Pharmaceutical Reference Standard
37. Sr-05000002278-2
38. Q13567664
39. Glucopyranoside, Eriodictyol-7 6-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
40. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one
41. (2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-4-one
42. (s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)chroman-4-one
43. (s)-3',4',5,7-tetrahydroxyflavanone-7-[6-o-(alpha-l-rhamnopyranosyl)-beta-d-glucopyranoside]
44. 4h-1-benzopyran-4-one, 7-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2s)-
45. 4h-1-benzopyran-4-one,7-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2s)-
46. Flavanone, 3',4',5,7-tetrahydroxy-, 7-(6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
Molecular Weight | 596.5 g/mol |
---|---|
Molecular Formula | C27H32O15 |
XLogP3 | -1.4 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 6 |
Exact Mass | 596.17412031 g/mol |
Monoisotopic Mass | 596.17412031 g/mol |
Topological Polar Surface Area | 245 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 924 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 11 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?